Highbridge Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,224	Closed	-$2.74M	–	544
2018 Q3	$2.74M	Buy	+14,224	New	+$2.53M	0.09%	292
2018 Q1	–	Sell	-15,000	Closed	-$2.25M	–	1962
2017 Q4	$2.25M	Buy	+15,000	New	+$2.22M	0.06%	368
2017 Q3	–	Sell	-1,900	Closed	-$245K	–	1970
2017 Q2	$245K	Sell	1,900 -26,037	-93%	-$3.13M	0.01%	1038
2017 Q1	$3.06M	Buy	27,937 +22,937	+459%	+$2.02M	0.06%	380
2016 Q4	$368K	Hold	5,000	–	–	0.01%	886
2016 Q3	$436K	Buy	+5,000	New	+$473K	0.01%	846
2016 Q2	–	Sell	-13,980	Closed	-$1.11M	–	1898
2016 Q1	$1.11M	Buy	+13,980	New	+$1.26M	0.02%	697
2015 Q4	–	Sell	-19,852	Closed	-$2.07M	–	1932
2015 Q3	$2.07M	Buy	+19,852	New	+$2.55M	0.04%	538
2015 Q2	–	Sell	-3,201	Closed	-$378K	–	1800
2015 Q1	$378K	Buy	+3,201	New	+$384K	0.01%	1048
2014 Q3	–	Sell	-88,359	Closed	-$8.37M	–	1434
2014 Q2	$8.37M	Buy	+88,359	New	+$6.2M	0.13%	205
2013 Q4	–	Sell	-123,181	Closed	-$9.34M	–	1419
2013 Q3	$9.34M	Buy	123,181 +30,844	+33%	+$2.45M	0.11%	242
2013 Q2	$7.39M	Buy	+92,337	New	+$6.8M	0.09%	268